Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Newsroom > News Release    

Scientists Identify a Brain Mechanism Underlying Persistent Cocaine Craving

For Release May 25, 2008

Finding May Lead to New Treatments to Decrease Risk of Relapse

Scientists have identified a mechanism in the brain that helps to explain why craving for cocaine, and the risk of relapse, seems to increase in the weeks and months after drug use is stopped. The research was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

The study1 published in the May 25 issue of the journal Nature, "reveals a novel mechanism for why cocaine craving intensifies after cessation of drug use and suggests a new target for the development of medications to decrease the risk of relapse in abstinent cocaine abusers," says NIDA Director Dr. Nora Volkow.

Exposure to environmental cues (e.g., people, places, things) previously associated with drug use can trigger drug craving, often leading to relapse. Previous NIDA-funded research using a rat model of drug craving and relapse (published in Nature in 20012) has shown that the responsiveness of rats to cocaine cues progressively increases, rather than decreases, over the first 60 days after cessation of intravenous cocaine self-administration.

In the current study, also in rats, researchers demonstrate that after prolonged periods of forced abstinence from cocaine self-administration, there is an increase in the number of proteins called AMPA glutamate receptors in a brain region known as the nucleus accumbens (a brain area involved in motivation and reward). "The additional AMPA receptors increase the reactivity of the nucleus accumbens to cocaine-related environmental cues, explaining the intensified cue-induced cocaine seeking that occurs after prolonged abstinence from the drug," explains lead investigator Marina E. Wolf, Ph.D., Professor and Chair of Neuroscience at the Rosalind Franklin University of Medicine and Science in North Chicago. "This happens not only because there are more AMPA receptors, but also because the new AMPA receptors are atypical - they are missing a particular subunit, and therefore enable stronger stimulation of the nucleus accumbens than typical AMPA receptors," adds Wolf.

When the investigators blocked these atypical receptors (termed GluR2-lacking AMPA receptors) after prolonged abstinence from cocaine, they were able to substantially decrease intensified cue-induced craving in the rat model. "The finding suggests," says Wolf, "that medications could be developed to block the atypical GluR2-lacking AMPA receptors in the nucleus accumbens, thus reducing drug craving and the risk for relapse, without interfering with neurotransmission at typical AMPA receptors, which are important for normal brain functions such as learning and memory."

The research was performed in the laboratories of Wolf, Michela Marinelli, Ph.D., and Kuei Y. Tseng, M.D., Ph.D., at Rosalind Franklin University of Medicine and Science and Yavin Shaham, Ph.D., of the NIDA Intramural Research Program in Baltimore, Maryland.

1 Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, Marinelli M, Wolf ME. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature, May 25, 2008
2 Grimm JW, Hope BT, Wise RA, Shaham Y. Incubation of cocaine craving after withdrawal. Nature 2001;412(6843):141-2.


The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and further information on NIDA research can be found on the NIDA web site at http://www.drugabuse.gov.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov


NIDA News Release Logo

For more information about any item in this Release Contact:

Get Adobe Reader

Download PDF [80 KB]


Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal